 | • レポートコード：D005-00829 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、早期分娩治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。早期分娩治療の種類別市場規模（子宮収縮抑制薬、ベータ–ミメティック、カルシウムチャネルブロッカー、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質）、用途別市場規模（病院、小児科及び新生児クリニック、老人ホーム、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Cipla、Sanofi、Novartis、AstraZeneca、Merck、GSK、Johnson and Johnson ・地域別グローバル市場分析 2015年-2020年 ・早期分娩治療の北米市場（アメリカ、カナダ、メキシコ） ・早期分娩治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・早期分娩治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・早期分娩治療の南米市場（ブラジル、アルゼンチン） ・早期分娩治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：子宮収縮抑制薬、ベータ–ミメティック、カルシウムチャネルブロッカー、NSAIDS、コルチコステロイド、硫酸マグネシウム、抗生物質 ・用途別分析：病院、小児科及び新生児クリニック、老人ホーム、薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Preterm Labor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Preterm Labor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Preterm Labor Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Preterm Labor Treatment market has been segmented into:
Tocolytic Drugs
Beta – Mimetic
Calcium Channel Blockers
NSAIDS
Corticosteroids
Magnesium Sulphate
Antibiotics
By Application, Preterm Labor Treatment has been segmented into:
Hospitals
Pediatric and Neonatal Clinics
Nursing Homes
Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Preterm Labor Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Preterm Labor Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Preterm Labor Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Preterm Labor Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Preterm Labor Treatment Market Share Analysis
Preterm Labor Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Preterm Labor Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Preterm Labor Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Preterm Labor Treatment are:
Pfizer
Cipla
Sanofi
Novartis
AstraZeneca
Merck
GSK
Johnson and Johnson
Table of Contents
1 Preterm Labor Treatment Market Overview
1.1 Product Overview and Scope of Preterm Labor Treatment
1.2 Classification of Preterm Labor Treatment by Type
1.2.1 Global Preterm Labor Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Preterm Labor Treatment Revenue Market Share by Type in 2019
1.2.3 Tocolytic Drugs
1.2.4 Beta – Mimetic
1.2.5 Calcium Channel Blockers
1.2.6 NSAIDS
1.2.7 Corticosteroids
1.2.8 Magnesium Sulphate
1.2.9 Antibiotics
1.3 Global Preterm Labor Treatment Market by Application
1.3.1 Overview: Global Preterm Labor Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Pediatric and Neonatal Clinics
1.3.4 Nursing Homes
1.3.5 Pharmacy
1.4 Global Preterm Labor Treatment Market by Regions
1.4.1 Global Preterm Labor Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Preterm Labor Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Preterm Labor Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Preterm Labor Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Preterm Labor Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Preterm Labor Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Preterm Labor Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Preterm Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cipla
2.2.1 Cipla Details
2.2.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cipla SWOT Analysis
2.2.4 Cipla Product and Services
2.2.5 Cipla Preterm Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Preterm Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Preterm Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca Preterm Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Preterm Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK Preterm Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson and Johnson
2.8.1 Johnson and Johnson Details
2.8.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson and Johnson SWOT Analysis
2.8.4 Johnson and Johnson Product and Services
2.8.5 Johnson and Johnson Preterm Labor Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Preterm Labor Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Preterm Labor Treatment Players Market Share
3.2.2 Top 10 Preterm Labor Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Preterm Labor Treatment Revenue and Market Share by Regions
4.2 North America Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
5 North America Preterm Labor Treatment Revenue by Countries
5.1 North America Preterm Labor Treatment Revenue by Countries (2015-2020)
5.2 USA Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
6 Europe Preterm Labor Treatment Revenue by Countries
6.1 Europe Preterm Labor Treatment Revenue by Countries (2015-2020)
6.2 Germany Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
6.4 France Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Preterm Labor Treatment Revenue by Countries
7.1 Asia-Pacific Preterm Labor Treatment Revenue by Countries (2015-2020)
7.2 China Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
7.5 India Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
8 South America Preterm Labor Treatment Revenue by Countries
8.1 South America Preterm Labor Treatment Revenue by Countries (2015-2020)
8.2 Brazil Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Preterm Labor Treatment by Countries
9.1 Middle East & Africa Preterm Labor Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Preterm Labor Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Preterm Labor Treatment Market Forecast by Type (2019-2024)
10.3 Tocolytic Drugs Revenue Growth Rate (2015-2025)
10.4 Beta – Mimetic Revenue Growth Rate (2015-2025)
10.5 Calcium Channel Blockers Revenue Growth Rate (2015-2025)
10.6 NSAIDS Revenue Growth Rate (2015-2025)
10.7 Corticosteroids Revenue Growth Rate (2015-2025)
10.8 Magnesium Sulphate Revenue Growth Rate (2015-2025)
10.9 Antibiotics Revenue Growth Rate (2015-2025)
11 Global Preterm Labor Treatment Market Segment by Application
11.1 Global Preterm Labor Treatment Revenue Market Share by Application (2015-2020)
11.2 Preterm Labor Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Pediatric and Neonatal Clinics Revenue Growth (2015-2020)
11.5 Nursing Homes Revenue Growth (2015-2020)
11.6 Pharmacy Revenue Growth (2015-2020)
12 Global Preterm Labor Treatment Market Size Forecast (2021-2025)
12.1 Global Preterm Labor Treatment Market Size Forecast (2021-2025)
12.2 Global Preterm Labor Treatment Market Forecast by Regions (2021-2025)
12.3 North America Preterm Labor Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Preterm Labor Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Preterm Labor Treatment Revenue Market Forecast (2021-2025)
12.6 South America Preterm Labor Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Preterm Labor Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Preterm Labor Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Preterm Labor Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Preterm Labor Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Preterm Labor Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Preterm Labor Treatment Major Business
Table 7. Pfizer Preterm Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Preterm Labor Treatment Product and Solutions
Table 10. Pfizer Preterm Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Cipla Corporate Information, Location and Competitors
Table 12. Cipla Preterm Labor Treatment Major Business
Table 13. Cipla Preterm Labor Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Cipla SWOT Analysis
Table 15. Cipla Preterm Labor Treatment Product and Solutions
Table 16. Cipla Preterm Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Corporate Information, Location and Competitors
Table 18. Sanofi Preterm Labor Treatment Major Business
Table 19. Sanofi Preterm Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Preterm Labor Treatment Product and Solutions
Table 22. Sanofi Preterm Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Preterm Labor Treatment Major Business
Table 25. Novartis Preterm Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Preterm Labor Treatment Product and Solutions
Table 28. Novartis Preterm Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AstraZeneca Corporate Information, Location and Competitors
Table 30. AstraZeneca Preterm Labor Treatment Major Business
Table 31. AstraZeneca Preterm Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 32. AstraZeneca SWOT Analysis
Table 33. AstraZeneca Preterm Labor Treatment Product and Solutions
Table 34. AstraZeneca Preterm Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Corporate Information, Location and Competitors
Table 36. Merck Preterm Labor Treatment Major Business
Table 37. Merck Preterm Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Merck SWOT Analysis
Table 39. Merck Preterm Labor Treatment Product and Solutions
Table 40. Merck Preterm Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. GSK Corporate Information, Location and Competitors
Table 42. GSK Preterm Labor Treatment Major Business
Table 43. GSK Preterm Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 44. GSK SWOT Analysis
Table 45. GSK Preterm Labor Treatment Product and Solutions
Table 46. GSK Preterm Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Johnson and Johnson Corporate Information, Location and Competitors
Table 48. Johnson and Johnson Preterm Labor Treatment Major Business
Table 49. Johnson and Johnson Preterm Labor Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Johnson and Johnson SWOT Analysis
Table 51. Johnson and Johnson Preterm Labor Treatment Product and Solutions
Table 52. Johnson and Johnson Preterm Labor Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Preterm Labor Treatment Revenue (Million USD) by Players (2015-2020)
Table 54. Global Preterm Labor Treatment Revenue Share by Players (2015-2020)
Table 55. Global Preterm Labor Treatment Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Preterm Labor Treatment Revenue Market Share by Regions (2015-2020)
Table 57. North America Preterm Labor Treatment Revenue by Countries (2015-2020)
Table 58. North America Preterm Labor Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Europe Preterm Labor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Preterm Labor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Preterm Labor Treatment Revenue by Countries (2015-2020)
Table 62. South America Preterm Labor Treatment Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Preterm Labor Treatment Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Preterm Labor Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Global Preterm Labor Treatment Revenue (Million USD) by Type (2015-2020)
Table 66. Global Preterm Labor Treatment Revenue Share by Type (2015-2020)
Table 67. Global Preterm Labor Treatment Revenue Forecast by Type (2021-2025)
Table 68. Global Preterm Labor Treatment Revenue by Application (2015-2020)
Table 69. Global Preterm Labor Treatment Revenue Share by Application (2015-2020)
Table 70. Global Preterm Labor Treatment Revenue Forecast by Application (2021-2025)
Table 71. Global Preterm Labor Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Preterm Labor Treatment Picture
Figure 2. Global Preterm Labor Treatment Revenue Market Share by Type in 2019
Figure 3. Tocolytic Drugs Picture
Figure 4. Beta – Mimetic Picture
Figure 5. Calcium Channel Blockers Picture
Figure 6. NSAIDS Picture
Figure 7. Corticosteroids Picture
Figure 8. Magnesium Sulphate Picture
Figure 9. Antibiotics Picture
Figure 10. Preterm Labor Treatment Revenue Market Share by Application in 2019
Figure 11. Hospitals Picture
Figure 12. Pediatric and Neonatal Clinics Picture
Figure 13. Nursing Homes Picture
Figure 14. Pharmacy Picture
Figure 15. Global Preterm Labor Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Preterm Labor Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Preterm Labor Treatment Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Preterm Labor Treatment Revenue Market Share in 2019
Figure 24. Global Top 10 Players Preterm Labor Treatment Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Preterm Labor Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Preterm Labor Treatment Revenue Market Share by Regions (2015-2020)
Figure 28. Global Preterm Labor Treatment Revenue Market Share by Regions in 2018
Figure 29. North America Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Europe Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 32. South America Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 34. North America Preterm Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. North America Preterm Labor Treatment Revenue Market Share by Countries in 2019
Figure 36. USA Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Canada Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Europe Preterm Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Preterm Labor Treatment Revenue Market Share by Countries in 2019
Figure 41. Germany Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 42. UK Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 43. France Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Russia Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Italy Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Preterm Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Preterm Labor Treatment Revenue Market Share by Countries in 2019
Figure 48. China Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Japan Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Korea Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 51. India Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 53. South America Preterm Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. South America Preterm Labor Treatment Revenue Market Share by Countries in 2019
Figure 55. Brazil Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Preterm Labor Treatment Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Preterm Labor Treatment Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 60. UAE Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Preterm Labor Treatment Revenue and Growth Rate (2015-2020)
Figure 63. Global Preterm Labor Treatment Revenue Share by Type (2015-2020)
Figure 64. Global Preterm Labor Treatment Revenue Share by Type in 2019
Figure 65. Global Preterm Labor Treatment Market Share Forecast by Type (2021-2025)
Figure 66. Global Tocolytic Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global Beta – Mimetic Revenue Growth Rate (2015-2020)
Figure 68. Global Calcium Channel Blockers Revenue Growth Rate (2015-2020)
Figure 69. Global NSAIDS Revenue Growth Rate (2015-2020)
Figure 70. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 71. Global Magnesium Sulphate Revenue Growth Rate (2015-2020)
Figure 72. Global Antibiotics Revenue Growth Rate (2015-2020)
Figure 73. Global Preterm Labor Treatment Revenue Share by Application (2015-2020)
Figure 74. Global Preterm Labor Treatment Revenue Share by Application in 2019
Figure 75. Global Preterm Labor Treatment Market Share Forecast by Application (2021-2025)
Figure 76. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 77. Global Pediatric and Neonatal Clinics Revenue Growth Rate (2015-2020)
Figure 78. Global Nursing Homes Revenue Growth Rate (2015-2020)
Figure 79. Global Pharmacy Revenue Growth Rate (2015-2020)
Figure 80. Global Preterm Labor Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Preterm Labor Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Preterm Labor Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Preterm Labor Treatment Revenue Market Forecast (2021-2025)
Figure 84. Europe Preterm Labor Treatment Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Preterm Labor Treatment Revenue Market Forecast (2021-2025)
Figure 86. South America Preterm Labor Treatment Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Preterm Labor Treatment Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
胎児（分娩・出産）＆新生児ケア機器の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Fetal (Labor & Delivery) And Neonatal Care Equipment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…- バーター症候群治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome T…
- 卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…
- 十二指腸潰瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Duodenal Ulcer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Duodenal Ulcer Treat…
- 肺炎治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pneumonia Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pneumonia Treatment…